Hahn, MN
Jerad J. Hahn, Orono, MN US
Patent application number | Description | Published |
---|---|---|
20120185292 | MEDICAL IMAGING DEVICE QUALITY CONTROL SYSTEM AND METHOD - A method in a computer system is provided for managing medical imaging devices quality control information. In particular, a method and corresponding computer devices are described for evaluating stored quality control test plan data for each of the one or more medical imaging devices being managed on an evaluation date. | 07-19-2012 |
20130268294 | SYSTEM AND METHOD FOR MANAGING MEDICAL IMAGING PROFESSIONAL CERTIFICATIONS - In accordance with one embodiment of the present invention, professional certifications functionality is provided by a mammography management system that allows system users such as radiologist and technologists to track their professional credentials such as licenses, certifications, and education. The functionality is flexible such that a variety of credential types may be entered and stored in the system and so that the progress of such credentials are tracked and monitored for relevant continuing education requirements. | 10-10-2013 |
John Hahn, Apple Valley, MN US
Patent application number | Description | Published |
---|---|---|
20090187035 | Process for production of fatty acid alkyl esters - A system and method for producing fatty acid alkyl esters is provided. The method includes forming a reactant stream, which includes triacylglycerides, alkanol, basic transesterification catalyst and, optionally, glycerol, and mixing the reactant stream under high shear mixing conditions to provide a mixed stream comprising fatty acid alkyl ester. | 07-23-2009 |
John J. Hahn, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20100099857 | METHOD OF PRODUCING PURIFIED REBAUDIOSIDE A COMPOSITIONS USING SOLVENT/ANTISOLVENT CRYSTALLIZATION - The invention provides methods of purifying rebaudioside A from a mixture comprising glycosides of the plant | 04-22-2010 |
John J. Hahn, Apple Valley, MN US
Patent application number | Description | Published |
---|---|---|
20160031792 | RECOVERY OF 3-HYDROXYPROPIONIC ACID - A method for recovering a composition enriched in 3-hydroxypropionic acid from a fermentation broth comprising 3-hydroxypropionic acid and/or salts thereof comprises the steps of: (a) providing the fermentation broth having a pH of from about 2 to about 8 comprising: 3-hydroxypropionic acid and/or salts thereof, (b) acidifying the fermentation broth; (c) reducing the total sulfate ion and phosphate ion (d) distilling the resulting reduced ion aqueous solution and (e) recovering the product. | 02-04-2016 |
John J. Hahn, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20110010154 | SYSTEM AND METHOD FOR OPTIMIZING ANIMAL PRODUCTION - A system for generating an animal feed formulation based on utilization of nutrients received by an animal. The system includes a simulator engine configured to generate a set of animal requirements based on characteristics of an animal and to generate animal feed formulation input based at least in part on a projected nutrient utilization for the animal and the set of animal requirements. The system further includes a formulator engine configured to receive the animal feed formulation input and generate an optimized animal feed formulation based on the animal feed formulation input. | 01-13-2011 |
John Joseph Hahn, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20110087011 | SEPARATION OF REBAUDIOSIDE A FROM STEVIA GLYCOSIDES USING CHROMATOGRAPHY - Disclosed are methods for the chromatographic separation of rebaudioside A from stevioside in glycoside solutions that are derived from stevia. The chromatographic separation may be an adsorb/desorb type of chromatographic separation or a fractionation type of chromatographic separation. | 04-14-2011 |
20120058236 | SWEETENER COMPOSITION COMPRISING HIGH SOLUBILITY FORM OF REBAUDIOSIDE A AND METHOD OF MAKING - Disclosed are sweetener compositions comprising rebaudioside A and methods of making the sweetener compositions. The sweetener compositions comprise a highly soluble crystal form of rebaudioside A that displays, in some embodiments, a solubility at 24° C. in water of about 25 (grams rebaudioside A/per 100 grams water) or greater. The high solubility of the sweetener composition of the invention allows it to be used in applications such as syrups and concentrates. | 03-08-2012 |
20120289687 | METHODS TO TREAT MIXTURES OF GLYCOSIDES TO OBTAIN ONE OR MORE OF THESE GLYCOSIDES IN MORE PURE FORM - The present invention provides methods to treat mixtures containing natural rebaudioside A (Reb A), rebaudioside B (Reb B), and rebaudioside D (Reb D), synthetic counterparts of these, and/or derivatives of the natural or synthetic embodiments obtain one or more of these glycosides in more pure form. In many embodiments, the invention can be used to process glycoside mixtures obtained at least in part from natural sources such as the | 11-15-2012 |
Patricia W. Hahn, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20100068349 | REDUCED SUGAR SWEET ROLL - A low or no sugar sweet roll product or intermediate is provided wherein at least a portion of the sweetness of the sweet roll product is provided by a non-nutritive sweet flavorant provided in combination with at least one sugar alcohol having a molecular weight less than about 350. Additionally, specific formulations of non-nutritive sweet flavorant with defined sugar alcohols and/or polydextrose are provided when the non-nutritive sweet flavorant and sugar alcohol is in the filling component or the icing component of the sweet roll product or intermediate. | 03-18-2010 |
20100215805 | BARRIER-COATED INGREDIENT FOR READY-TO-BAKE COOKIE DOUGH - A ready-to-bake cookie dough product containing a barrier coated cinnamon ingredient is described. The barrier coated cinnamon substantially reduces or eliminates the formation of gray dough in the cookie dough product when the cookie dough product is stored under refrigerated or frozen conditions. The barrier coated cinnamon ingredient includes cinnamon coated with a high SFI fat. Other ingredients, such as spices or flavorings, can also be prepared using the barrier coating to reduce or eliminate the formation of gray dough or other discoloration or forms of deterioration in ready-to-bake dough products. | 08-26-2010 |
Stephen J. Hahn, Shoreview, MN US
Patent application number | Description | Published |
---|---|---|
20100016920 | SYSTEMS AND METHODS FOR COLLECTING PATIENT EVENT INFORMATION - A method of and system for collecting patient event information from a cardiac rhythm management system (CRM system) is described, where the CRM system includes a cardiac rhythm management device (CRM device) and an external interface device. The method includes the steps of initiating a transmission session wherein the interface device communicates with the CRM device, prompting a user of the CRM system to select a reason for the transmission session, inputting the selected reason for the transmission session to the interface device, and storing the selected reason for the transmission session and timestamp information for the transmission session. | 01-21-2010 |
20110093026 | METHOD AND APPARATUS FOR CARDIORENAL ELECTRICAL STIMULATION - An implantable cardiorenal stimulator delivers cardiorenal stimulation in response to detection of decompensation associated with heart failure. The cardiorenal stimulation includes delivering renal stimulation pulses to promote diuresis and/or natriuresis and delivering cardiac stimulation pulses to enhance the diuretic and/or natriuretic effects of the renal stimulation pulses. | 04-21-2011 |
20120143286 | SYSTEMS AND METHODS FOR INCREASING STIMULATION DOSE - According to an embodiment of a method performed by an implantable medical device to deliver a neural stimulation therapy to a patient, a lower dose of the neural stimulation therapy is delivered to the patient. The dose of the neural stimulation therapy is automatically increased from the lower dose to a higher dose, and the higher dose of the neural stimulation therapy is delivered to the patient. A trigger that is controlled by the patient is detected, and the dose of the neural stimulation therapy is automatically returned from the higher dose back to the lower dose in response to detecting the trigger. | 06-07-2012 |
20120303086 | SYSTEMS AND METHODS FOR COLLECTING PATIENT EVENT INFORMATION - A method of and system for collecting patient event information is described, where the system includes an implantable medical (IMD) and an external interface device. The external interface device is remote from the IMD and includes a communication module, a display device adapted to prompt a user of the system to select a reason for a particular transmission session and a user input device adopted to accept input indicating a selected reason. | 11-29-2012 |
20130053914 | METHOD AND APPARATUS FOR ADAPTIVE CONTROL OF NEUROSTIMULATION USING CARDIAC RESTITUTION - A neurostimulation system measures a cardiac parameter at various cardiac intervals and analyzes its restitution, including computing a restitution slope being a rate of change of the restitution parameter with respect to change in the cardiac interval. In various embodiments, the system uses the restitution slope to provide for adaptive control of neurostimulation. In various embodiments, one or more cardiac parameters such as action potential duration (APD), conduction velocity (CV), QT interval (QT), and/or T-wave morphology (TM) parameter are measured and analyzed for restitution of each parameter, which is then used to control the delivery of the neurostimulation. | 02-28-2013 |
20130053926 | SYSTEMS TO DETECT VAGUS CAPTURE - Some embodiments provide a system for delivering neurostimulation. Some system embodiments comprise a lead configured to be implanted in the body, a stimulation output circuit configured to deliver neurostimulation pulses to the vagus nerve through the lead, an EMG sensing circuit configured to use the lead to sense EMG signals from laryngeal muscle activity, and an evoked muscular response detection circuit configured to use the EMG signals sensed by the EMG sensing circuit to detect evoked laryngeal muscle activity evoked by the neurostimulation pulse. | 02-28-2013 |
20130158621 | ECTOPIC-TRIGGERED PARA-HIS STIMULATION - Ectopic cardiac activity can be detected, such as in the absence of a diagnosed tachyarrhythmia episode. In response to the detected ectopic activity, electrostimulation can be provided to a para-Hisian region, such as to activate natural cardiac contraction mechanisms or to interrupt re-entrant cardiac activity. Subsequent ectopic cardiac activity can be detected, and subsequent electrostimulation can be provided to the para-Hisian region, such as according to one or more adjustable electrostimulation parameters. | 06-20-2013 |
20130345591 | METHOD FOR DETECTING VAGUS CAPTURE - Some embodiments provide a system for delivering neurostimulation. Some system embodiments comprise a lead configured to be implanted in the body, a stimulation output circuit configured to deliver neurostimulation pulses to the vagus nerve through the lead, an EMG sensing circuit configured to use the lead to sense EMG signals from laryngeal muscle activity, and an evoked muscular response detection circuit configured to use the EMG signals sensed by the EMG sensing circuit to detect evoked laryngeal muscle activity evoked by the neurostimulation pulse. | 12-26-2013 |